Loading…
Loading…
Fresenius Medical is scaling its 5008X rollout across U.S. clinics, creating growth potential despite volume, reimbursement and rollout-cost pressures.
Fresenius Medical's improving profitability, 5008X rollout and value-based care gains offer support despite volume and reimbursement risks.
Fresenius Medical Care AG and Co. KGaA (NYSE: FMS - Get Free Report) shares passed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $23.13 and traded as high as $23.92. Fresenius Medical Care AG and Co. KGaA shares last traded at $23.43,
These stocks have economic moats and look attractive today.
Fresenius Medical Care AG and Co. KGaA (NYSE: FMS) reported second-quarter 2026 organic revenue growth of 5% and a 23% increase in operating income at constant currency, while confirming its full-year outlook despite weaker U.S. treatment volumes and anticipated reimbursement-related headwinds in the second half. Chief Executive Officer Helen Giza said the company's operating-income growth accelerated
FMS posts 28% EPS growth as Care Delivery profitability and margin gains offset a quarterly revenue miss and weaker US treatment volumes.
Silicon Motion Technology Corporation (NasdaqGS: SIMO) (âSilicon Motionâ), a global leader in designing and marketing NAND flash controllers for solid-state
TAIPEI, Taiwan--(BUSINESS WIRE)-- #AIStorage--Silicon Motion Technology Corporation (NasdaqGS: SIMO) (“Silicon Motion”), a global leader in designing and marketing NAND flash controllers for solid-state storage devices, today announced it will showcase its latest storage innovations for AI Factory, Edge AI, and Physical AI applications at Future of Memory and Storage (FMS) 2026, taking place August 4 to 6 in Santa Clara, California, at Booth #315. As AI evolves beyond large language model training toward Ag.